Chad Messer
Stock Analyst at Lake Street
(1.09)
# 3,728
Out of 4,534 analysts
500
Total ratings
37%
Success rate
-0.5%
Average return
Main Sectors:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Reiterated: Buy | $6 | $5.14 | +16.73% | 1 | Jul 16, 2026 | |
| OSTX OS Therapies | Maintained: Buy | $13 | $1.51 | +760.93% | 19 | Jul 7, 2026 | |
| PSTV Plus Therapeutics | Reiterated: Buy | $50 | $3.83 | +1,205.48% | 6 | Jul 1, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $103 | $105.90 | -2.74% | 7 | Jun 30, 2026 | |
| GNLX Genelux | Maintained: Buy | $16 | $2.93 | +446.08% | 6 | Jun 30, 2026 | |
| CGEN Compugen | Reiterated: Buy | $6 → $5 | $2.34 | +113.68% | 3 | Jun 24, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $32 | $13.55 | +136.16% | 1 | Jun 11, 2026 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $5 | $0.85 | +488.24% | 18 | Jun 1, 2026 | |
| IMNM Immunome | Maintained: Buy | $30 | $22.16 | +35.38% | 9 | Jun 1, 2026 | |
| COYA Coya Therapeutics | Maintained: Buy | $17 | $4.44 | +282.88% | 14 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $2.95 | +747.46% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $4.48 | +1,575.98% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.05 | - | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $8.18 | n/a | 18 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 340.00 → kr 380.00 | kr 183.00 | n/a | 13 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.44 | n/a | 17 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $7.78 | n/a | 7 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $6.82 | n/a | 5 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.0001 | n/a | 11 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $87.99 | n/a | 2 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $79.11 | n/a | 31 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $5.40 | n/a | 13 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $1.28 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $97.33 | n/a | 19 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.40 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $45.88 | n/a | 25 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 | $52.95 | n/a | 50 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.0001 | n/a | 17 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $22.71 | n/a | 6 | Jul 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $30 | $55.53 | n/a | 22 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $83 | $1.79 | n/a | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $166 | $16.83 | n/a | 50 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.3052 | n/a | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.06 | n/a | 21 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.79 | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $13.50 | n/a | 3 | Apr 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $33 | $6.24 | n/a | 10 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.00004 | n/a | 5 | May 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $4 | $12.48 | n/a | 6 | Mar 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.33 | n/a | 1 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.82 | n/a | 1 | May 22, 2012 |
AVITA Medical
Jul 16, 2026
Reiterated: Buy
Price Target: $6
Current: $5.14
Upside: +16.73%
OS Therapies
Jul 7, 2026
Maintained: Buy
Price Target: $13
Current: $1.51
Upside: +760.93%
Plus Therapeutics
Jul 1, 2026
Reiterated: Buy
Price Target: $50
Current: $3.83
Upside: +1,205.48%
Monopar Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $103
Current: $105.90
Upside: -2.74%
Genelux
Jun 30, 2026
Maintained: Buy
Price Target: $16
Current: $2.93
Upside: +446.08%
Compugen
Jun 24, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $2.34
Upside: +113.68%
Kazia Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.55
Upside: +136.16%
Oncolytics Biotech
Jun 1, 2026
Maintained: Buy
Price Target: $5
Current: $0.85
Upside: +488.24%
Immunome
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $22.16
Upside: +35.38%
Coya Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $17
Current: $4.44
Upside: +282.88%
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $2.95
Upside: +747.46%
May 13, 2026
Maintained: Buy
Price Target: $75
Current: $4.48
Upside: +1,575.98%
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.05
Upside: -
Nov 1, 2021
Maintained: Buy
Price Target: $6 → $7
Current: $8.18
Upside: n/a
Sep 1, 2021
Reiterated: Buy
Price Target: kr 340.00 → kr 380.00
Current: kr 183.00
Upside: n/a
Aug 17, 2021
Rated: Buy
Price Target: $3
Current: $1.44
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $29
Current: $7.78
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $49
Current: $6.82
Upside: n/a
Aug 10, 2021
Maintained: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $50
Current: $87.99
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $48
Current: $79.11
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $30
Current: $5.40
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $10
Current: $1.28
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $12
Current: $97.33
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $21
Current: $1.40
Upside: n/a
Aug 4, 2021
Rated: Hold
Price Target: n/a
Current: $45.88
Upside: n/a
Aug 4, 2021
Rated: Buy
Price Target: $84
Current: $52.95
Upside: n/a
Jul 29, 2021
Rated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Jul 15, 2021
Rated: Buy
Price Target: $48
Current: $22.71
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $33 → $30
Current: $55.53
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $75 → $83
Current: $1.79
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $166
Current: $16.83
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $10
Current: $0.3052
Upside: n/a
May 10, 2021
Rated: Hold
Price Target: n/a
Current: $40.06
Upside: n/a
Nov 8, 2019
Rated: Hold
Price Target: n/a
Current: $3.79
Upside: n/a
Apr 12, 2018
Maintained: Buy
Price Target: $30 → $27
Current: $13.50
Upside: n/a
Dec 9, 2016
Reiterated: Buy
Price Target: $6 → $33
Current: $6.24
Upside: n/a
May 7, 2015
Reiterated: Buy
Price Target: $10 → $7
Current: $0.00004
Upside: n/a
Mar 6, 2015
Maintained: Buy
Price Target: $7 → $4
Current: $12.48
Upside: n/a
Jan 5, 2015
Initiated Coverage: Buy
Price Target: $17
Current: $1.33
Upside: n/a
May 22, 2012
Initiated Coverage: Buy
Price Target: $5
Current: $1.82
Upside: n/a